L'Air Liquide, Société Anonyme pour I'Etude et I'Exploitation des Procédés Georges Claude;L'Institut du Cerveau et de la Moelle Epiniere
发明人:
Patrick MICHEL,Jérémie LAVAUR,Etienne HIRSCH,Marc LEMAIRE
申请号：
US15316227
公开号：
US20170189445A1
申请日:
2015.06.08
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The invention relates to a drug combination including gaseous xenon and at least one NMDA receptor antagonist in liquid or solid form. In order to treat or slow tumour proliferation of cells in the contral nervous system in a human being, in particular astrocyte glia and/or the percursors thereof. The NMDA receptor antagonist is perferably memantine or altromemantine. The proportion of xenonis 10% to 80% by volume.
